Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Biotec Betaglucans AS

Closing information (x1000 DKK)

Closing information 2024/01 2023/01 2022/01
Turnover 21,219 Less Arrow 11,127 More Arrow 19,250
Financial expenses 1,167 More Arrow 1,478 Less Arrow 111
Earnings before taxes 2,244 Less Arrow 1,621 More Arrow 49,155
Total assets 21,827 Less Arrow 15,538 More Arrow 19,538
Current assets 16,592 Less Arrow 13,500 More Arrow 17,923
Current liabilities 12,642 Less Arrow 6,212 More Arrow 6,747
Equity capital 9,186 More Arrow 9,326 More Arrow 12,791
- share capital 657 More Arrow 687 More Arrow 743

Financial ratios

Fiscal year 2024/01 2023/01 2022/01
Solvency 42.1% More Arrow 60.0% More Arrow 65.5%
Turnover per employee
Profit as a percentage of turnover 10.6% More Arrow 14.6% More Arrow 255.4%
Return on assets (ROA) 15.6% More Arrow 19.9% More Arrow 252.2%
Current ratio 131.2% More Arrow 217.3% More Arrow 265.6%
Return on equity (ROE) 24.4% Less Arrow 17.4% More Arrow 384.3%
Change turnover 10,586 Less Arrow -6,674 Less Arrow -17,631
Change turnover % 100% Less Arrow -37% Less Arrow -48%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/01 2023/01 2022/01
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.